Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective

Joe M. O'Sullivan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

Alpha emitters have always promised to deliver potential benefit in cancer therapy. Using the example of radium-223 (Xofigo) and the paradigm of ionising radiation, this review looks at targeted alpha therapy from the perspective of a radiation oncologist.

Original languageEnglish
Pages (from-to)S31-S33
Number of pages3
JournalJournal of Medical Imaging and Radiation Sciences
Volume50
Issue number4, Supplement 1
Early online date16 Aug 2019
DOIs
Publication statusPublished - 01 Dec 2019

Bibliographical note

Publisher Copyright:
© 2019

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

Keywords

  • prostate cancer
  • Targeted alpha therapy

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective'. Together they form a unique fingerprint.

Cite this